Sassicaia Capital Advisers LLC Quant / Systematic

CIK: 0001692751 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $4,136 (100.0% shares, 0.0% debt)

Holdings (7)

QQQ INVESCO QQQ TR 69.2%

Value ($000) $2,863 Shares 5,600 Est. Cost $499.31 Unrealized —

MRNA MODERNA INC 14.6%

Value ($000) $603 Shares 14,500 Est. Cost $47.80 Unrealized 0.0%

— CYBERARK SOFTWARE LTD 8.1%

Value ($000) $333 Shares 1,000 Est. Cost $333.15 Unrealized —

— UNITED STATES STL CORP NEW 6.6%

Value ($000) $272 Shares 8,000 Est. Cost $33.99 Unrealized —

NRXP NRX PHARMACEUTICALS INC 0.8%

Value ($000) $33 Shares 15,000 Est. Cost $1.34 Unrealized 0.0%

— AETHLON MED INC 0.7%

Value ($000) $31 Shares 36,000 Est. Cost $0.86 Unrealized —

— HAOXI HEALTH TECHNOLOGY LTD 0.0%

Value ($000) $2 Shares 10,000 Est. Cost $0.15 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
QQQ	INVESCO QQQ TR	5,600	$2,863	69.2%	$499.31	—	UNIT SER 1	46090E103
MRNA	MODERNA INC	14,500	$603	14.6%	$47.80	0.0%	COM	60770K107
—	CYBERARK SOFTWARE LTD	1,000	$333	8.1%	$333.15	—	SHS	M2682V108
—	UNITED STATES STL CORP NEW	8,000	$272	6.6%	$33.99	—	COM	912909108
NRXP	NRX PHARMACEUTICALS INC	15,000	$33	0.8%	$1.34	0.0%	COM NEW	629444209
—	AETHLON MED INC	36,000	$31	0.7%	$0.86	—	COM NEW	00808Y406
—	HAOXI HEALTH TECHNOLOGY LTD	10,000	$2	0.0%	$0.15	—	USD CL A ORD SHS	G4290F100